Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Makoto Inoue, Kyorin University
ClinicalTrials.gov Identifier:
NCT01758757
First received: December 27, 2012
Last updated: December 31, 2012
Last verified: December 2012
  Purpose

Surgical outcome of vitreous surgery for proliferative diabetic retinopathy (PDR) with conventional 20, 23, and 25-gauge vitrectomy were compared.


Condition Intervention
Proliferative Diabetic Retinopathy
Procedure: Vitrectomy

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Comparison of Small-gauge and Conventional Vitrectomy for Proliferative Diabetic Retinopathy

Resource links provided by NLM:


Further study details as provided by Kyorin University:

Primary Outcome Measures:
  • Incidence of retinal breaks [ Time Frame: One year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Incidence of neovascular glaucoma [ Time Frame: One Year ] [ Designated as safety issue: No ]

Enrollment: 347
Study Start Date: September 2007
Study Completion Date: July 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Proliferative diabetic retinopathy Procedure: Vitrectomy

Detailed Description:

The 424 eyes of 347 patients of PDR who underwent vitreous surgery for persistent vitreous hemorrhage or progressive proliferative membrane were evaluated.

  Eligibility

Ages Eligible for Study:   10 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patients of proliferative diabetic retinopathy who underwent vitreous surgery and followed at least 6 months

Exclusion Criteria:

  • The patients of proliferative diabetic retinopathy who underwent vitreous surgery but did not follow more than 6 months.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01758757

Locations
Japan
Kyorin Eye Center
Mitaka, Tokyo, Japan, 181-8611
Sponsors and Collaborators
Kyorin University
Investigators
Study Chair: Makoto Inoue, MD Kyorin Eye Center
  More Information

No publications provided

Responsible Party: Makoto Inoue, Kyorin Eye Center, Kyorin University
ClinicalTrials.gov Identifier: NCT01758757     History of Changes
Other Study ID Numbers: Kyorineye010, Vitrectomy for PDR
Study First Received: December 27, 2012
Last Updated: December 31, 2012
Health Authority: Japan: Institutional Review Board

Keywords provided by Kyorin University:
Proliferative diabetic retinopathy
Vitrectomy

Additional relevant MeSH terms:
Diabetic Retinopathy
Retinal Diseases
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 26, 2014